INTRODUCTION
The shortcomings of standard protamine zinc insulin when used alone in a single daily injection for the treatment of so-called "severe" diabetes are well known (1) (2) (3) (4) . Post-prandial glycosuria, nocturnal hypoglycemia, or both, are common and are directly attributed to its slow, gradual but variable rate of absorption from the subcutaneous depot (5) . Consequently, increasing attention has been directed during the past several years toward developing a depot insulin whose activity would be distributed more in keeping with the physiological needs of the diabetic. Several preparations intermediate in time-action between ordinary unmodified insulin and standard protamine zinc insulin have been proposed. Of these the most promising and extensively studied are modifications of standard protamine zinc insulin (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) and globin insulin with zinc (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) .
The modifications of standard protamine zinc insulin include premixed and extemporaneous mixtures of unmodified or crystalline insulin with standard protamine zinc insulin in various proportions (5) (6) (7) (8) (9) (10) (11) (12) , specially modified protamine zinc insulin, type NP-50 (13) (14) (15) and more recently specially modified insulin types NPC-40 and NPH-50 (12) . The most popular and widely used mixture seems to be the pre-mixed, unbuffered "2: 1 mixture" (9) (10) (11) (12) , made by mixing thoroughly two parts of unmodified or crystalline insulin with one part of standard protamine zinc insulin. The physical nature and principal consti- 1 Aided by grants from Eli Lilly and Company, and from the Hochstetter Fund of the University of Rochester School of Medicine and Dentistry. 2 The insulins used in these studies were supplied through the courtesy of Eli Lilly and Company. 8 tuents of the insulins mentioned are outlined in Table I . In a previous report (33) the time action curves and solubility properties of all of these intermediate insulins were compared. This paper deals with a quantitative comparison of five of these insulins 5 at the clinical level. No report has appeared previously in the literature in which all of these insulins have been compared clinically in the same group of patients.
PLAN OF INVESTIGATION
Patients. Nineteen women patients with diabetes mellitus were used in this investigation. Throughout the period of study, which in each case extended over several weeks, they lived quietly in the hospital under carefully controlled uniform conditions. They observed normal sleep and waking habits. Activity was restricted to being up and about on the hospital floors ad libitum.
The subjects selected do not represent a random sample of the population of our diabetic clinic. They were selected specifically to obtain a wide range in age, duration of diabetes, insulin requirements, and stability, as outlined in Table II . Since the classification of the patients on the basis of stability is important in the later interpretation of results it is pertinent to digress a moment to discuss it more fully.
It became obvious early in the investigation that despite meticulous control of the external factors the response in some cases was strikingly different from that in others. Observations of the types of patients under investigation impressed one of us with the fact that it is possible to separate out two rough clinical groups irrespective of amount of exogenous insulin required or type of insulin used. These have been called the relatively stable group (Patients 1-7) and the relatively unstable group . No sharp line of demarcation is possible between the groups. Nevertheless, in most instances a classification could be made without difficulty after a sufficient period of observation under controlled conditions.
In the unstable group control was difficult. Control is 5 NP-50 insulin was omitted because its manufacture had been discontinued at the time this investigation was started. 44  5  74  7  70  96  170  1,824   44  44  6  74  4  70  90  170  1,770   35  35  7  67  i  87  98  183  1,962  15  35  8  44  14  81   84   160  1,720   20  22  9  53  7  72  46  150  1,392  50  30  10  21  1  92  94  171  1,898   240  200  11  22  1  81  94  181  1,898  48  46  12  39   10  69  138  164  2,674   24  30  13  58  5  94  106  195  2,010  48  40  14  66  13  77  93  188  1,897  56  56  15  14  3  90  100  248   2,260  75   140  16  21  6  95  101  200  2,170  75  50  17  28  23  60  71  182   1,607   48  52  18  55  24  71  100  150  1,784  28   34  19  24  5   76  72  171  1,546  40  55 ISIS insulin while the mid-afternoon feeding was routine with globin insulin with zinc. The pattern of in-between feedings was less consistent with the modifications of standard protamine zinc insulin. As a rule the diets (see Table II The volume of the original data makes it impractical to present them in their entirety.. A summary of the original data is presented in Tables III and IV. The purpose of these tables is only to provide the reader with a general impression of the levels and variability of the blood and urinary sugar determinations during the period of study.
A CLINICAL COMPARISON OF MODIFIED INSULINS
The primary problem in the analysis of these data is a descriptive one. The extent of the data makes it difficult to determine by inspection whether there are consistencies of patient response reflected by blood and urinary sugar levels which relate to type of insulin received. A striking feature in the blood and urinary sugar levels in diabetics is their variability in contrast to their constancy in non-diabetics. Hence, a reasonable basis for comparing insulins is their effect on this variability. The total variability among the blood or urinary sugar levels for each patient on each insulin has been divided into two components, intraand inter-daily variability. The intra-daily variation is the variability among the four determinations (of blood or urinary sugar) in a single day. To measure this variation monotonic functions of the variance 6 of the four readings in a single day have been used. Precise definitions of intra-daily variation for blood and urinary sugar are given in the appendix.
The inter-daily variation is the variability among the average blood or urinary sugar levels from one day to another. In order to compare the different kinds of insulin it would not be pertinentJto have the measure of inter-daily variation include variability resulting from changes in unit dose from one day to the next. Inter-daily variation should include only that variability remaining when the patient is treated as nearly identically as pos- 6 The variance of a set of numbers is an average of the squared differences between the numbers and their mean. The use of the variance as a measure of variability is discussed in any standard text on statistics, e.g., Snedecor (36) . Protariine zinc sible for each of a series of days. The period of observation for each patient while receiving one kind of insulin has been divided into "groups" of days. A "group" of days is a series of consecutive days on which a single patient received the same unit dose of the same kind of insulin. Inter-daily variation is then measured separately for each "group" of days in a manner similar to that for intra-daily variation. Precise definitions of interdaily variation are given in the appendix.
The choice of particular measures of intra-and inter-daily variability is to a large extent arbitrary. The measures used in this analysis were chosen because they possess certain desirable statistical properties.
Each patient provides one estimate of her intradaily variation in both blood and urinary sugar on each day of observation. When these are averaged over all days on which the patient received the same kind of insulin, the insulins may be compared on their ability to control intra-daily variability. Similarly, each patient provides one estimate of her inter-daily variation during each "group" of days of observation. These may be averaged over all "groups" of days during which the patient received the same kind of insulin in order to com- (36) . It has been assumed throughout that changes in dose within the ranges same patterns as the blood sugars they have not been presented. encountered had negligible effects on any of the measures of response used. The validity of this assumption is supported by the lack of any apparent relation when any of the measures of response is plotted against unit dose. It has also been necessary to assume that the changes in diet distribution which were necessary in some of the patients had, at worst, a leveling effect on the quantities investigated. Hence, when differences associated with kind of insulin are observed it is felt that they would be larger rather than smaller if diet distribution had been entirely uniform over all insulins for each patient.
RESULTS
Intra-daily variation. On the present measurement scale intra-daily variation in blood sugar ranges from about 2.00 in non-diabetics to about 5.00 for the highest value obtained in this investigation. The value for non-diabetics was calculated from published .data (37) . Although these data are not directly comparable with those of the present study, the value so obtained provides an approximate normal level for intra-daily variation in blood sugar.
Table V presents the average values for intradaily variation in blood sugar for each patient on each insulin. In the eight patients marked with the asterisk the probability of obtaining the observed results on the hypothesis that the true intra-daily variation is the same with each of the insulins tested is less than 5%. In these patients, then, it is decided that there are changes in the level of intra-daily variation associated with changes in kind of insulin administered. (7) 10 0.28 (3) 0.08 (6) 0.37 (8) 0.33 (4) 11 1.31 (13) 0.86 (6) 0.99 (6) 1.43 (5) 1.33 (6) 12 0.33 (3) 0.45 (6) 0.43 (4) 0.83 (4) 0.69 (4) 13 0.54 (4) 0.58 (7) 0.66 (13) 1.11 (7) 0.40 (8) 14* 0.77 (15) 0.60 (8) 1.63 (9) 1.28 (6) 15 16 1.00 (6) (8) 1.23 (7) 1.03 (6) 1.64 (4) 19* 1.86 (8) 2.32 (3) 1.32 (8) 1.65 (4) * The patients marked with the asterisk are those showing significant differences among insulins. 8-19. inter-daily variation in blood sugar obtained here was about 5.50 . No direct estimate of this quantity was available for non-diabetics. Calculated "guesses" based on published data (37) in which non-diabetics were observed for just one day place the figure in the neighborhood of 2.50. Inter-daily variation in urinary sugar ranges from zero in individuals showing no glycosuria to about 3.00 for the highest value in this study.
Table VII presents the average values for interdaily variation in blood sugar. In no case are the differences associated with insulins sufficiently large to indicate anything except sampling variation. Average values of inter-daily variation in urinary sugar are shown in Table VIII . In this respect there also seems to be no real difference among insulins.
Mean deviations from the daily mean. The results of this part of the analysis are presented graphically in Figures 1-5 average over all the days on which the patient received the given insulin. If the lines were plotted separately for each day the high variability in the (2) 0.50 (1) shape from one day to another on the same insulin would be apparent. In spite of this large variability, however, statistical analysis supports the view that the consistency of the pattern is not a chance effect and that the apparent differences in pattern shown in Figures 1-5 are real differences. This consistency in pattern not only shows itself during any two days from the same period on a given insulin, but also in any two days from different periods on the same insulin.
In the stable group (Part A of Figures 1-5 ) the patterns for the different insulins are essentially the same. The three modifications of standard protamine zinc insulin produce patterns in the unstable group (Part B of Figures 1, 2 and 3) , which are not only indistinguishable from one another but also similar to the patterns of the stable group. On the other hand, globin insulin with zinc and standard protamine zinc insulin produce patterns in the unstable group which are strikingly different from those of the other three insulins. The pattern of globin insulin with zinc displays a consistent tendency toward high points at 7:30 a.m. and 11:30 a.m. and low points at 4:30 p.m. (2) .,6C .~~~~~~~~~~~~~~~~~~. 1 of insulin without showing symptoms of hypoglycemia." It should be pointed out that Himsworth's description of insulin-sensitive and insulininsensitive diabetics describes exactly the unstable and stable diabetics respectively. It would thus seem that generally speaking the stable diabetic is relatively insensitive to insulin whereas the unstable diabetic is relatively sensitive to insulin. However, a given patient's sensitivity to insulin fluctuates. At one time a given dose may invoke a profound hypoglycemia and yet the same dose may have little effect at another time. This is particularly true in the unstable patient and may give some insight into the occasional lack of agreement between the laboratory tests and clinical grouping of patients noted by both Himsworth and Falta. The general classification on the basis of stability is therefore considered preferable. It might be added that the so-called "brittle" diabetic (40, 41) is merely an example of marked instability.
Since the patients studied are not a random sample of the diabetic population, they provide no estimate of the true proportion of unstable diabetics. The series is biased in favor of the unstable group because it is felt that these are the patients in whom insulin timing is more critical.
Some idea of the proportion of relatively unstable patients in the general diabetic population may be gleaned from the fact that in our diabetic clinic with a population between 250 and 300 the unstable group comprises probably not more than 25% of the entire group.
The importance of stability in the comparison of behavior of the different insulins is evident from the data presented. When the insulins are compared on their ability to control intra-and inter-daily variability, no large differences appear. Since intra-and inter-daily variations are measures of instability it becomes apparent that the ability -of the insulins tested to affect stability is negligible.
In spite of the best possible control of extraneous factors (diet, environment, and insulin) a certain basic instability remains, the degree of which is characteristic for each patient.
In contrast with extent of intra-daily variability, the pattern of intra-daily variability is affected differently by the insulins, though notable only in the unstable group of patients. In the stable group no serious timing defects are noted for any of the insulins studied. The patterns of distribution of insulin activity as described by the mean deviations from the daily mean of the blood sugar, at the times selected, are nearly level. The patterns are not only remarkably comparable from patient to patient, but even from insulin to insulin. For all practical purposes none of the insulins studied possesses any significant advantage over another in this group.
In the unstable group timing defects are brought into sharp focus. Globin insulin with zinc displays a consistent tendency to produce hypoglycemia in the late afternoon or evening. At the same time its action is too weak overnight to control adequately the morning fasting levels. The so-called "over-lapping" effect from dose to dose which is considered important in controlling post-breakfast hyperglycemia and glycosuria is either feeble or lacking altogether. The action of standard protamine zinc insulin is, in certain respects, opposite to that of globin insulin with zinc. Its action is too weak to control adequately post-prandial hyperglycemia and glycosuria. At the same time it has a distinct tendency to produce hypoglycemia overnight. In other words, a fault common to both insulins is too much activity at one time and too little at another. In contrast, the three modifications of standard protamine zinc insulin appear to have a more balanced distribution of insulin activity over a 24 hour period.
It is noteworthy that reactions to insulin were fewer, milder or less precipitous with any of the three modifications of standard protamine zinc insulin than with globin insulin with zinc or standard protamine zinc insulin. Also of interest is the observation that subcutaneous injections of any of the protamine insulins studied were decidedly less apt to cause local discomfort (immediate "burning" or "stinging" pain) than those of globin insulin with zinc.
Observations on the behaviour of the insulins in question have been continued in each of the 19 patients under their routine living conditions following discharge from the hospital. They have been followed at regular intervals (two to four weeks) through the facilities of the out-patient department for periods extending to as much as three years. Although the data obtained from this "follow-up study" do not permit quantitative comparisons, the general pattern of response to the different insulins is essentially the same as that already described. As a matter of fact, the increased physical activity of the patients incidental to pursuing their routine -way of life has tended, if anything, to accentuate the timing defects. Finally, clinical experience with the insulins in question in over 100 patients followed on an out-patient status substantiates the opinions which have been formulated on the basis of the controlled studies presented.
The striking discrepancy in the performance of globin insulin with zinc and standard protamine zinc insulin in the two groups may be connected with the problem of homeostasis. In the stable patient any inherent defect in timing of the given insulin may be compensated for or minimized by homeostatic mechanisms which seem to be functioning to some extent; while in the unstable patient in whom the homeostatic mechanisms appear to be seriously disrupted and insulin timing more critical, any inherent faults stand out glaringly. For this reason comparison of time-action curves of various insulins in stable patients or in normal laboratory animals (31-33) cannot be strictly correlated with comparison of clinical responses to the same insulins. Difference in timing tends to be minimized in stable patients and accentuated in unstable patients. Some insight into the nature and mechanism of the observed defects of globin insulin with zinc and standard protamine zinc insulin is afforded by some nephelometric .studies on the combining properties of protamine and globin for insulin reported in part in a previous paper (33) . These studies have been extended and will be considered in detail in a separate communication (42) . The diurnal rhythm factor in diabetics (43) may also serve to aggravate the timing defects of globin insulin with zinc. There is a natural tendency for the blood sugar to fall during the day and rise during the night in a typical rhythmic fashion. The lowest levels are generally reached in the late afternoon or early evening and the highest levels by early morning. In other words, globin insulin with zinc, when administered in a single daily injection before breakfast, produces a strong effect when the blood sugar is at its lowest and, at most, a very weak effect when the blood sugar is at its highest. SUMMARY 1. Each of five different insulin preparations (the "2: 1 mixture," specially modified insulin types NPC-40 and NPH-50, standard protamine zinc insulin, and globin insulin with zinc) have been compared in each of 19 women patients with diabetes mellitus under routine but controlled conditions in the hospital. The blood and urinary sugar responses to each insulin have been determined in each patient over periods of several consecutive days (mode of five days).
2. The patients have been divided into two rough groups, the relatively stable group and the relatively unstable group, primarily on the basis of the variability of the blood and urinary sugar responses. In the stable group the variability was relatively low whereas in the unstable group it was excessively high. The insulins have been compared in each patient on their ability to control the extent of, or to influence the pattern of, this variability.
3. The insulins showed no differential ability to control the extent of the variability of blood and urinary sugar response or, in other words, stability. On the other hand, type of insulin did influence the pattern of this variability, but only in the unstable group. The three modifications of standard protamine zinc insulin (the 2: 1 mixture, type NPC-40 and type NPH-50) produced a nearly level pattern in the variability in this group, i.e., no conspicuously high or low points. In contrast, globin insulin with zinc gave consistently high points in the morning and low points in the afternoon or evening while standard protamine zinc insulin produced consistently low points in the morning and high points in the afternoon or evening. The results indicate that clinical insulin comparisons without a consideration of stability may be very misleading.
APPENDIX
Let w, x, y and z denote the four blood sugar determinations for one patient on one day: then the intra-daily variation in blood sugar for that patient and day is defined to be:
